IN motion

Andrés Moreno-Estrada and Carmina Barberena-Jonas: building scientific independence in LATAM

By Emma Bishop, RARE Revolution

8 September 2025

IN motion

Dr David Kuter: On a pipeline therapy for haematological disorders

By Nicola Miller, RARE Revolution

1 September 2025

IN motion

Sondra Butterworth: Why building trust is the cornerstone of PPIE

By CONTRIBUTOR

25 August 2025

IN motion

MfRD: RDI-Lancet commission for rare disease

By Emma Bishop, RARE Revolution

18 August 2025

IN motion

Sumair Nizamuddin: Rebuilding trust in medical research and delivery

By Nicola Miller, RARE Revolution

11 August 2025

IN motion

Putting you in the heart of the rare community – CDKL5 UK

By CONTRIBUTOR

4 August 2025

IN motion

One 2Treat: Revolutionising clinical trials

By Nicola Miller, RARE Revolution

28 July 2025

IN motion

Tobias Hagedorn: Stretched thin

By Nicola Miller, RARE Revolution

21 July 2025

IN motion

Michael Wilbur: Finding industries’ voices in awareness campaigns, and is it time to drop the zebra?

By Michael Wilbur, MW Advocacy Solutions

14 July 2025

IN motion

Gareth Baynam: From songlines to science – Bridging healthcare and Indigenous culture

By Emma Bishop, RARE Revolution

7 July 2025

IN motion

Dr Kate Cameron on championing diversity in research sampling

By Nicola Miller, RARE Revolution

30 June 2025

IN motion

Helene Cederroth: Solving the unsolvable – A revolutionary new model for diagnosing rare diseases

By Emma Bishop, RARE Revolution

23 June 2025

IN motion

Casey McPherson: AlphaRose Therapeutics on doing things differently

By Nicola Miller, RARE Revolution

7 June 2025

IN motion

Dr Sara ten Have discusses the environmental impact of peptides in drug development

By Nicola Miller, RARE Revolution

7 June 2025